A must have for all sports lovers, this premium quality Bonafide Revaree Plus – Drug-Free, Hormone-Free Vaginal Moisturizer with 10mg Hyaluronic Acid and Sweet Almond Oil – 2 Month Supply features a 100% polyester fabric which provides excellent comfort and durability. The Bonafide Revaree Plus – Drug-Free, Hormone-Free Vaginal Moisturizer with 10mg Hyaluronic Acid and Sweet Almond Oil – 2 Month Supply boasts a state-of-the-art fit which is made to be a perfect fit.
EXTRA-MOISTURIZING RELIEF: Uniquely formulated with hyaluronic acid and soothing sweet almond oil, Revaree Plus is a deeply hydrating moisturizer that’s clinically validated to relieve vaginal dryness in as little as 7 days.1
NO HORMONES & NO HARMFUL SIDE EFFECTS: Results of 4 head-to-head clinical trials show that the hyaluronic acid in Revaree Plus is as effective at relieving dryness as topical estrogen creams.2-6
Bonafide Revaree Plus – Drug-Free, Hormone-Free Vaginal Moisturizer with 10mg Hyaluronic Acid and Sweet Almond Oil – 2 Month Supply products are available for purchase in a variety of styles and colors. Buy an authentic Bonafide Revaree Plus – Drug-Free, Hormone-Free Vaginal Moisturizer with 10mg Hyaluronic Acid and Sweet Almond Oil – 2 Month Supply for the best price.
RESULTS BACKED BY CLINICAL TRIALS: Data indicates that, with Revaree Plus, 100% of women reduced vaginal dryness, 98% reduced irritation, and 87% reduced painful sex.6
WORKS WITH YOUR BODY, NOT AGAINST IT: Formulated with 2x hyaluronic acid and soothing sweet almond oil, the hormone-free formula in Revaree Plus replenishes natural moisture all day, every day, for sustained comfort.
LIFE-CHANGING RELIEF: In a study of 967 Bonafide customers, 71% of women say Bonafide products changed their lives for the better, and 97% say they’d refer the products to a friend suffering from the same problem.
Resources 1. Ongoing open-label clinical trial. 2. Chen J, et al. J Sex Med. 2013;10:1575-1584. 3. Agrawal S et al. Menopause. 2023;30(12):1247-1305. 4. Jokar A, et al. IJCBNM. 2016;4(1):69-78. 5. Ilhan G et al. Journal of Menopausal Medicine. 2021;27(1):15. 6. Open-label clinical trial. Internal report.
